DexCom, Inc.’s (NASDAQ:DXCM) third-quarter 2025 revenue reached $1.209 billion, beating the analyst consensus estimate of $1.179 billion.

Revenue grew 22% year-over-year on a reported basis and 20% year-over-year on an organic basis.

U.S. revenue grew 21% and international revenue grew 22% on a reported basis and 18% on an organic basis, all on a year-over-year basis.

GAAP operating income was $242.5 million or 20.1% of revenue, an increase of 480 basis points compared to the third quarter of 2024.

Adjusted operating income reached $272.9 million or 22.6% of reported revenue, an increase of 130 basis points from a year ago.

DexCom reported adjusted earnings of 61 cents, beating the consensus of 57 cents.

Also Read: DexCom Faces New Reports Of ...